1. Home
  2. UVE vs ORIC Comparison

UVE vs ORIC Comparison

Compare UVE & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNIVERSAL INSURANCE HOLDINGS INC

UVE

UNIVERSAL INSURANCE HOLDINGS INC

HOLD

Current Price

$31.25

Market Cap

971.3M

Sector

Finance

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$10.72

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVE
ORIC
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.3M
1.1B
IPO Year
1992
2020

Fundamental Metrics

Financial Performance
Metric
UVE
ORIC
Price
$31.25
$10.72
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$18.78
AVG Volume (30 Days)
157.3K
1.2M
Earning Date
10-23-2025
11-13-2025
Dividend Yield
2.47%
N/A
EPS Growth
70.32
N/A
EPS
4.23
N/A
Revenue
$1,580,798,000.00
N/A
Revenue This Year
$1.87
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.36
N/A
Revenue Growth
4.61
N/A
52 Week Low
$18.72
$3.90
52 Week High
$35.84
$14.93

Technical Indicators

Market Signals
Indicator
UVE
ORIC
Relative Strength Index (RSI) 39.92 37.26
Support Level $31.80 $10.45
Resistance Level $33.58 $12.14
Average True Range (ATR) 1.02 0.81
MACD -0.45 -0.09
Stochastic Oscillator 8.71 11.92

Price Performance

Historical Comparison
UVE
ORIC

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: